ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease

Feng, Jiayao; Liu, Yongjian; Chen, Jiajia; Bai, Yan; He, Jincan; Cao, Hua; Che, Qishi; Guo, Jiao*; Su, Zhengquan*广东药学院
Marine Drugs2022-6DOI: 10.3390/md20060383
11被引21阅读
引用收藏
分享

摘要

In this study, C57BL/6 mice were given an HFHSD diet for 8 weeks to induce hepatic steatosis and then given COSM solution orally for 12 weeks. The study found that the HFHSD diet resulted in steatosis and insulin resistance in mice. The formation of NAFLD induced by HFHSD diet was related to the imbalance of intestinal flora. However, after COSM intervention, the abundance of beneficial bacteria increased significantly, while the abundance of harmful bacteria decreased significantly. The HFHSD diet also induced changes in intestinal bacterial metabolites, and the content of short-chain fatty acids in cecal contents after COSM intervention was significantly higher than that in the model group. In addition, COSM not only improved LPS levels and barrier dysfunction in the ileum and colon but upregulated protein levels of ZO-1, occludin, and claudin in the colon and downregulated the liver LPS/TLR4/NF-kappa B inflammatory pathway. We concluded that the treatment of marine chitooligosaccharide COSM could improve the intestinal microflora structure of the fatty liver and activate an inflammatory signaling pathway, thus alleviating the intrahepatic lipid accumulation induced by HFHSD.

学科与关键词

关键词
marine chitooligosaccharidenonalcoholic fatty liver diseaseintestinal floraLPS/TLR4/NF-kappa B inflammatory pathwayshort-chain fatty acid
相关
加载中…
  • Ameliorating the effect and mechanism of chitosan oligosaccharide on nonalcoholic fatty liver disease in mice
    Zhang, Jiahua; Feng, Jiayao; Bai, Yan; Che, Qishi; Cao, Hua; Guo, Jiao*; Su, Zhengquan*Food & Function, 2023, 14(23): 10459-10474.
  • GOS Ameliorates Nonalcoholic Fatty Liver Disease Induced by High Fat and High Sugar Diet through Lipid Metabolism and Intestinal Microbes
    Qiu, Shuting; Chen, Jiajia; Bai, Yan; He, Jincan; Cao, Hua; Che, Qishi; Guo, Jiao*; Su, Zhengquan*OncoImmunology, 2022, 14(13): 2749.被引 10
  • Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism
    Li, Feng; Zhang, Zhengyan; Bai, Yan; Che, Qishi; Cao, Hua; Guo, Jiao*; Su, Zhengquan*MOLECULES, 2023, 28(19): 6918.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Marine Drugs
发表日期
2022-06
卷期
第 20 卷, 第 6 期
页码
383
DOI
10.3390/md20060383
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Science and Technology Program of Guangzhou, China [202103000089]; Guangdong Demonstration Base for Joint Cultivation of Postgraduates (2019); Science Foundation for Distinguished Young Scholars of Guangdong [2020B1515020026]; National Natural Science Foundation of China [21804025]

作者

  • F

    Feng, Jiayao (第一作者)

    guangdong pharmaceut univ · new

  • L

    Liu, Yongjian

    guangdong pharmaceut univ · new

查看全部 9 位作者收起作者
  • C

    Chen, Jiajia

    guangdong pharmaceut univ · new

  • B

    Bai, Yan

    guangdong pharmaceut univ

  • H

    He, Jincan

    guangdong pharmaceut univ

  • C

    Cao, Hua

    guangdong pharmaceut univ

  • C

    Che, Qishi

  • G

    Guo, Jiao (通讯)

    guangdong pharmaceut univ

  • S

    Su, Zhengquan (通讯)

    guangdong pharmaceut univ · new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417